Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Medpace Holdings, Inc. (NASDAQ: MEDP). This legal action targets all individuals and entities who acquired Medpace common stock between April 22, 2025, and February 9, 2026. The lawsuit was filed in the United States District Court for the Southern District of Ohio.
Key Dates and Deadlines
Investors are encouraged to take note of the following important dates related to the lawsuit:
- Class Period: April 22, 2025, to February 9, 2026
- Deadline to Apply: June 5, 2026
Allegations Against Medpace
The lawsuit claims that Medpace engaged in practices that artificially inflated its share price by making false and misleading statements. Evidence of these misrepresentations became clear as the company reported disappointing performance during the class period.
As a result, many investors faced financial losses once the true situation of Medpace was disclosed.
Investor Actions
Individuals who purchased Medpace shares during the class period and sustained losses are urged to contact Bragar Eagel & Squire for more information. Additionally, investors who have relevant information or would like to understand their legal options should reach out as well.
Contact Information
You can contact:
- Brandon Walker: (212) 355-4648
- Melissa Fortunato: (212) 355-4648
- Email: [email protected]
There are no costs involved in seeking help regarding this lawsuit.
About Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. is a well-known law firm with offices in New York, South Carolina, and California. The firm specializes in representing both individual and institutional investors in various types of litigation, including securities, derivative, and commercial cases.
For more information, visit El-Balad.
